Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry

Abstract

IntroductionRefractory asthma represents a significant unmet clinical need where the evidence base for the assessment and therapeutic management is limited. The British Thoracic Society (BTS) Difficult Asthma Network has established an online National Registry to standardise specialist UK difficult asthma services and to facilitate research into the assessment and clinical management of difficult asthma.MethodsData from 382 well characterised patients, who fulfilled the American Thoracic Society definition for refractory asthma attending four specialist UK centres—Royal Brompton Hospital, London, Glenfield Hospital, Leicester, University Hospital of South Manchester and Belfast City Hospital—were used to compare patient demographics, disease characteristics and healthcare utilisation.ResultsMany demographic variables including gender, ethnicity and smoking prevalence were similar in UK centres and consistent with other published cohorts of refractory asthma. However, multiple demographic factors such as employment, family history, atopy prevalence, lung function, rates of hospital admission/unscheduled healthcare visits and medication usage were different from published data and significantly different between UK centres. General linear modelling with unscheduled healthcare visits, rescue oral steroids and hospital admissions as dependent variables all identified a significant association with clinical centre; different associations were identified when centre was not included as a factor.ConclusionWhilst there are similarities in UK patients with refractory asthma consistent with other comparable published cohorts, there are also differences, which may reflect different patient populations. These differences in important population characteristics were also identified within different UK specialist centres. Pooling multicentre data on subjects with refractory asthma may miss important differences and potentially confound attempts to phenotype this population.

Epidemiology and outcome of childhood asthma: a clinical study in an Egyptian university medical centre

“…Table 2 shows the relation between symptoms, risk factors and relieving factors and the outcome of an asthmatic attack, using the need for hospital admission as an indicator of the severity of an asthmatic attack. The need for hospital admission was significantly higher in those who complained of both United Kingdom [8,9]. Moreover, the prevalence of asthma in the 6-12 years age group shows a more than a 5-fold difference in prevalence between countries, ranging from 4.1%-32.1%, with the lowest rates in India, Indonesia, Islamic Republic of Iran and Malaysia and the highest rates in Australia, Brazil, Costa Rica, New Zealand and Panama [8,10].…”

Eosinophilia and Chronic Airway Diseases

“…The majority of asthmatic patients seen in secondary care in a UK centre had significant sputum eosinophilia 56 . Similarly, the majority of refractory asthmatics included in a UK registry had sputum eosinophils ≥ 3% 30 . The same was found in the Belgian severe asthma registry including more than 300 severe asthmatics, with 55% of patients being qualified as eosinophilic based on sputum eosinophil counts ≥ 3%, while only 20% had significantly raised sputum neutrophil count > 76% 57 .…”

Recent changes in the drug treatment of allergic asthma

“…The drug is administered subcutaneously on a 2-4 weekly basis, with the dose based on total IgE levels and weight. However, patients must fulfil certain criteria to be eligible and cost, dosing criteria and the absence of allergic factors in about 40% of patients with severe asthma 16 limit its use.…”